MYELODYSPLASIA
Clinical trials for MYELODYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New stem cell method aims to fight blood cancers with fewer side effects
Disease control OngoingThis study tests a special stem cell transplant for people with blood cancers like leukemia and lymphoma. Doctors use donor stem cells that have been filtered to remove certain immune cells, which may help the body accept the transplant and reduce harmful side effects like graft-…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Half-Matched stem cell transplant shows promise for blood cancer patients
Disease control OngoingThis study tested a stem cell transplant from a half-matched (haploidentical) donor in 21 adults with various blood cancers. The goal was to see how many patients survived and had successful engraftment at 100 days and one year. Researchers also looked at immune system recovery a…
Matched conditions: MYELODYSPLASIA
Phase: PHASE3 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Parent stem cells offer new hope for kids with blood cancer
Disease control OngoingThis study tests a new way to do stem cell transplants for 20 children with blood cancers or myelodysplasia who don't have a perfect donor match. Doctors remove certain immune cells from a parent's partially matched stem cells before transplant to help the new cells grow faster a…
Matched conditions: MYELODYSPLASIA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:58 UTC
-
Cord blood stem cells boost recovery in High-Risk cancer patients
Disease control OngoingThis study tests a new stem cell treatment (MGTA-456) made from umbilical cord blood for people with high-risk blood cancers like leukemia and lymphoma. About 22 patients will receive high-dose chemotherapy followed by the stem cell infusion. The goal is to see if this treatment …
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New cord blood transplant shows promise for tough leukemia cases
Disease control OngoingThis study tests a new way to use cord blood transplants for people with high-risk leukemia or myelodysplasia. The approach expands cord blood stem cells with a molecule called UM171 to improve recovery and reduce complications. About 30 participants will receive this transplant …
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Ciusss de L'Est de l'Île de Montréal • Aim: Disease control
Last updated Jun 08, 2026 13:17 UTC